Explore the full scope of our drug knowledge tailored for pharmaceutical research needs in our data library. Learn more.
If you are looking for more details, kindly visit Pregabalin Powder.
Explore a selection of our essential drug information below, or:
Unlock 38% more drug discovery time and eliminate decision-making doubts with this one-stop guide to quality drug data.
Pregabalin is structurally similar to gamma-aminobutyric acid (GABA) - an inhibitory neurotransmitter. 13 It may be used to manage neuropathic pain, postherpetic neuralgia, and fibromyalgia among other conditions. 20 Although as per the FDA Label the mechanism of action has not been definitively characterized, there is evidence that pregabalin exerts its effects by binding to the α2δ subunit of voltage-dependent calcium channels. 20 , 22 Pregabalin is marketed by Pfizer under the trade name Lyrica and Lyrica Cr (extended release). 21 , 22 It may have dependence liability if misused but the risk appears to be highest in patients with current or past substance use disorders. 4
Pregabalin is an anticonvulsant drug used to treat neuropathic pain conditions and fibromyalgia, and for the treatment of partial onset seizures in combination with other anticonvulsants.
Although the structure of pregabalin is similar to gamma-aminobutyric acid (GABA), it does not bind to GABA receptors.6,20 Instead, it binds the alpha2-delta subunit of presynaptic voltage-gated calcium channels in the central nervous system.6,20 Pregabalin does not modulate dopamine receptors, serotonin receptors, opiate receptors, sodium channels or cyclooxygenase activity.20
Although the mechanism of action has not been fully elucidated, studies involving structurally related drugs suggest that presynaptic binding of pregabalin to voltage-gated calcium channels is key to the antiseizure and antinociceptive effects observed in animal models.22
By binding presynaptically to the alpha2-delta subunit of voltage-gated calcium channels in the central nervous system, pregabalin modulates the release of several excitatory neurotransmitters including glutamate, substance-P, norepinephrine, and calcitonin gene related peptide.6 In addition, pregabalin prevents the alpha2-delta subunit from being trafficked from the dorsal root ganglia to the spinal dorsal horn, which may also contribute to the mechanism of action.15
Although pregabalin is a structural derivative of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA), it does not bind directly to GABA or benzodiazepine receptors.8
TargetActionsOrganismA
Voltage-dependent calcium channel subunit alpha-2/delta-1Not Available
HumansAfter oral dosing administered in the fasted state, pregabalin absorption is rapid, and extensive.8 Pregabalin oral bioavailability is reported to be 90% regardless of the dose.8 Cmax is attained within 1.5 hours after single or multiple doses, and steady state is attained within 24-48 hours with repeated administration.8,22 Both Cmax and AUC appear to be dose proportional.8
Food decreases the rate of pregabalin absorption and as a result, lowers the Cmax by an estimated 25-30% and increases the Tmax to approximately 3 hours.22 However, the effect of food does not appear to impact the total absorption of pregabalin in a way that is clinically relevant. As a result, pregabalin can be administered with or without food.22
After oral administration of pregabalin, the reported apparent volume of distribution is roughly 0.5 L/kg.22
Although pregabalin is not very lipophilic, it is able to cross the blood brain barrier(BBB).16 System L transporters facilitate the transport of large amino acids across the BBB and it has been confirmed that pregabalin is a substrate.22,16 This information suggests that system L transporters are responsible for pregabalin uptake into the BBB.16
In rat models, pregabalin has been shown to cross the placenta.22
Pregabalin is not plasma protein bound.8,22
Less than 2% of pregabalin is metabolized and it is excreted virtually unchanged in the urine.8,22
Hover over products below to view reaction partners
Pregabalin is almost exclusively eliminated in the urine.17,18
Further, based on preclinical studies, pregabalin does not appear to undergo racemization to the R enantiomer in the body.11
The elimination half life of pregabalin is 6.3 hours.22
In young healthy subjects the mean renal clearance is estimated to be 67.0 to 80.9 mL mL/min.22 Given pregabalin's lack of plasma protein binding, this clearance rate suggests that renal tubular reabsorption is involved.22
In a systematic review that included 38 randomized controlled trials, there were 20 identified adverse effects that were significantly associated with pregabalin, most of which involve the central nervous system and cognition. The identified adverse effects include vertigo, dizziness, balance disorder, incoordination, ataxia, blurred vision, diplopia, amblyopia, somnolence, confusional state, tremor, disturbance in attention, abnormal thinking, asthenia, fatigue, euphoria, edema, peripheral edema, dry mouth, and constipation 14.
The most common symptoms of pregabalin toxicity (dose range includes 800 mg/day and single doses up to 11,500 mg) include somnolence, confusion, restlessness, agitation, depression, affective disorder and seizures.23
Since there is no antidote for pregabalin overdose, patients should receive general supportive care. If appropriate, gastric lavage or emesis may help eliminate unabsorbed pregabalin (healthcare providers should take standard precautions to maintain the airway).23
Pregabalin pharmacokinetic properties suggest that extra-corporeal elimination methods including haemodialysis, may be useful in situations of severe toxicity.19 However, there are cases where patients have presented with very high serum levels of pregabalin and have been successfully managed with supportive care alone.19
Not Available
Not Available
Consumer Medicine Information (CMI) summary
The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist.
WARNING: Important safety information is provided in a boxed warning in the full CMI. Read before taking this medicine.
Noumed Pregabalin contains the active ingredient, pregabalin. Noumed Pregabalin is taken to treat neuropathic pain, which is pain caused by an abnormality of, or damage to, the nerves.
For more information, see Section 1. Why am I using Noumed Pregabalin? in the full CMI.
Do not use if you have ever had an allergic reaction to pregabalin or any of the ingredients listed at the end of the CMI.
Talk to your doctor if you have any other medical conditions, take any other medicines (including benzodiazepines and opioids), or are pregnant or plan to become pregnant or are breastfeeding.
For more information, see Section 2. What should I know before I take Noumed Pregabalin? in the full CMI.
Some medicines may interfere with Noumed Pregabalin and affect how it works.
A list of these medicines is in Section 3. What if I am taking other medicines? in the full CMI.
More instructions can be found in Section 4. How do I take Noumed Pregabalin? in the full CMI.
For more information, see Section 5. What should I know while taking Noumed Pregabalin? in the full CMI.
All medicines can have side effects. If you do experience any side effects, most of them are minor and temporary. Tell your doctor or pharmacist if you notice anything else that may be making you feel unwell.
Some common, less serious side effects include dizziness, feeling tired or drowsy, headache, unsteadiness when walking, reduced coordination, shaking or tremors, constipation, diarrhoea, nausea, dry mouth, blurred or double vision, abdominal pain, and increase in weight.
Serious side effects include unusual changes in mood or behaviour, increased irritability, anxiety or depression, thoughts of suicide, swelling of the face, lips, tongue, hands, ankles or feet, unexplained muscle pain, tenderness and weakness, irritated red eyes that are sensitive to light, and shortness of breath, wheezing or difficulty breathing.
For more information, including what to do if you have any side effects, see Section 6. Are there any side effects? in the full CMI.
WARNING:
Noumed Pregabalin as an add-on therapy for adults with partial onset seizures has not been established Noumed Pregabalin should be gradually decreased over a minimum period of 1 week to avoid seizures.
Before taking Noumed Pregabalin, tell your doctor if you have a history of drug abuse. Pregabalin poses risks of misuse, abuse and dependence. Using Noumed Pregabalin with other medicines that can make you feel drowsy such as sleeping tablets and other pain relievers (e.g. benzodiazepines and opioids), antihistamines, antidepressants, antipsychotics, cannabis, and alcohol may result in severe drowsiness, decreased awareness, breathing problems, coma and death. If you have any concern about taking this medicine, speak to your doctor.
Active ingredient(s): Pregabalin
Consumer Medicine Information (CMI)
This leaflet provides important information about taking Noumed Pregabalin. You should also speak to your doctor or pharmacist if you would like further information or if you have any concerns or questions about taking Noumed Pregabalin.
1. Why am I taking Noumed Pregabalin?
2. What should I know before I taking Noumed Pregabalin?
3. What if I am taking other medicines?
4. How do I take Noumed Pregabalin?
5. What should I know while taking Noumed Pregabalin?
6. Are there any side effects?
7. Product details
Noumed Pregabalin contains the active ingredient pregabalin.
Noumed Pregabalin belongs to a group of medicines called anticonvulsants and has pain relieving effects.
Noumed Pregabalin is used to treat neuropathic pain, which is pain caused by an abnormality of, or damage to, the nerves.
Do not take Noumed Pregabalin if:
Check with your doctor if you:
Pregabalin poses risks of misuse, abuse and dependence. Your body may become used to you taking Noumed Pregabalin and this may result in physical dependence. It means that you may experience withdrawal symptoms if you stop taking Noumed Pregabalin suddenly. So it is important to strictly follow the directions given by your doctor.
During treatment, you may be at risk of developing certain side effects. It is important you understand these risks and how to monitor for them. See additional information under Section 6. Are there any side effects?
Check with your doctor if you are pregnant or intend to become pregnant.
Explore more:Contact us to discuss your requirements of 2-bromo-4-methylpropiophenone synthesis. Our experienced sales team can help you identify the options that best suit your needs.
Talk to your doctor if you are breastfeeding or intend to breastfeed.
Noumed Pregabalin is not recommended for use during pregnancy.
Pregabalin use during the first 3 months of pregnancy may cause birth defects in the unborn child that require medical treatment. In a study reviewing data from women in Nordic countries who took pregabalin in the first 3 months of pregnancy, 6 babies in every 100 had such birth defects. This compares to 4 babies in every 100 born to women not treated with pregabalin in the study.
Abnormalities of the face (orofacial clefts), the eyes, the nervous system (including the brain), kidneys and genitals have been reported.
Effective contraception must be used by women of childbearing potential.
The active ingredient in Noumed Pregabalin passes into breast milk and its safety in infants is unknown. It is recommended that you do not breast-feed while taking Noumed Pregabalin.
Tell your doctor or pharmacist if you are taking any other medicines, including any medicines, vitamins or herbal supplements that you buy without a prescription from your pharmacy, supermarket, naturopath or health food shop.
Noumed Pregabalin and certain other medicines may influence each other (interaction).
Using Noumed Pregabalin with other medicines that can make you feel drowsy, such as sleeping tablets and other pain relievers (e.g. benzodiazepines and opioids), antihistamines, antidepressants, antipsychotics, cannabis, and alcohol may result in severe drowsiness, decreased awareness, breathing problems, coma and death. Your doctor will minimize the dose and duration of use; and monitor you for signs and symptoms of breathing difficulties and sedation.
You may need different amounts of your medicines, or you may need to take different medicines. Your doctor will advise you.
Check with your doctor or pharmacist if you are not sure about what medicines, vitamins or supplements you are taking and if these affect Noumed Pregabalin.
Noumed Pregabalin must be taken once daily after an evening meal.
If you miss your dose at the usual time, take it prior to bedtime following a snack.
If you miss the dose prior to bedtime, then take it following your morning meal.
If you do not take the dose the following morning, then take the next dose at your regular time after your evening meal.
Do not take a double dose to make up for the dose you missed.
If you think that you have taken too much Noumed Pregabalin, you may need urgent medical attention.
Symptoms of an overdose with Noumed Pregabalin may include mood changes, feeling tired, confusion, depression, agitation, restlessness or seizures.
You should immediately:
You should do this even if there are no signs of discomfort or poisoning.
Remind any doctor, dentist or pharmacist you visit that you are using Noumed Pregabalin.
If you have nervous system or respiratory disorders, kidney problems, or you are older than 65, your doctor may adjust your dose.
If you are going to have surgery, tell the surgeon or anaesthetist that you are taking this medicine it may affect other medicines taken during the procedure.
Call your doctor straight away if you:
Continue taking your medicine for as long as your doctor tells you.
This medicine helps to control your condition, but does not cure it. It is important to keep taking your medicine, even if you feel well.
Stopping Noumed Pregabalin suddenly may worsen your condition or increase your chance of experiencing withdrawal symptoms, such as sleeplessness, headache, nausea (feeling sick), anxiety, excessive sweating or diarrhoea (runny stools). If appropriate, your doctor will slowly reduce your dose before you can stop taking it completely.
If appropriate, your doctor will slowly reduce your dose before you can stop taking it completely.
Be careful before you drive or use any machines or tools until you know how Noumed Pregabalin affects you.
Noumed Pregabalin may cause dizziness in some people, with other anticonvulsant medicines. If you have any of these symptoms, do not drive, operate machinery or do not do anything else that could be dangerous
Tell your doctor if you drink alcohol.
Alcohol may interfere with Noumed Pregabalin and increase side effects such as sleepiness and dizziness.
Follow the instructions in the carton on how to take care of your medicine properly.
Store it in a cool dry place away from moisture, heat or sunlight; for example, do not store it:
Keep it where young children cannot reach it.
If you no longer need to use this medicine or it is out of date, take it to any pharmacy for safe disposal.
Do not use this medicine after the expiry date.
All medicines can have side effects. If you do experience any side effects, most of them are minor and temporary. However, some side effects may need medical attention.
See the information below and, if you need to, ask your doctor or pharmacist if you have any further questions about side effects.
Gastrointestinal related
Eye related
Body related
General effect
Musculoskeletal related
Eye related
Respiratory related
Tell your doctor or pharmacist if you notice anything else that may be making you feel unwell.
Other side effects not listed here may occur in some people.
After you have received medical advice for any side effects you experience, you can report side effects to the Therapeutic Goods Administration online at www.tga.gov.au/reporting-problems. By reporting side effects, you can help provide more information on the safety of this medicine.
Always make sure you speak to your doctor or pharmacist before you decide to stop taking any of your medicines.
This medicine is only available with a doctors prescription.
Do not take this medicine if you are allergic to any of these ingredients.
25 mg white to off white powder filled in size 4 hard gelatin white opaque and white opaque capsule linear printed in black ink with Cipla 25 mg on the cap and 677 on the body.
75 mg white to off white powder filled in size 4 hard gelatin orange opaque and white opaque capsule linear printed in black ink with Cipla 75 mg on the cap and 679 on the body.
150 mg white to off white powder filled in size 2 hard gelatin white opaque and white opaque capsule linear printed in black ink with Cipla 150 mg on the cap and 682 on the body.
300 mg white to off white powder filled in size 0 hard gelatin orange opaque and white opaque capsule linear printed in black ink with Cipla 300 mg on the cap and 685 on the body.
Each carton contains 56 capsules.
Blister pack-
AUST R ,
AUST R ,
AUST R ,
AUST R
Avallon Pharmaceuticals
Level 5, 7 Eden Park Drive,
Macquarie Park, NSW
Australia
: 930 999
This leaflet was prepared in January .
Published by MIMS April
For more Cas 59-46-1information, please contact us. We will provide professional answers.
Previous: Artificial Turf vs SBR Latex: Which is the Best?
Next: Zirconium Pretreatment Offers Simplicity and Performance
Comments
Please Join Us to post.
0